Ginkgo Bioworks Holdings DNA
NYSE DNA
$7.84 +0.78 (+11.05%)
As of: Sep 17, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Sales of Property, Plant and Equipment (2022 - 2025)

Analysis

Ginkgo Bioworks Holdings (DNA) Sales of Property, Plant and Equipment (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 574,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 400,000.00
Dec 31, 2023 1.43 Mn
Sep 30, 2023 74,000.00
Jun 30, 2023 2.31 Mn
Mar 31, 2023 617,000.00
Dec 31, 2022 -110,000.00
Sep 30, 2022 33,000.00
Jun 30, 2022 19,000.00
Mar 31, 2022 58,000.00